|
Facebook
Twitter
Linkedin
|
Aspyra, Inc. Demonstrating Solutions at NRHA Conference
| Company News - Aspyra, Inc. |
Aspyra, Inc. announced plans to demonstrate the latest release of their AccessRAD RIS/PACS and CyberLAB LIS products at the upcoming NRHA 2008 Annual Conference
Aspyra, Inc. today announced plans to demonstrate the latest release of their AccessRAD RIS/PACS and CyberLAB LIS products at the upcoming NRHA (National Rural Health Association) 2008 Annual Conference held at the Sheraton New Orleans in New Orleans, LA (May 7-10, 2008), Booth 518.
As a clinical and diagnostic solutions provider, Aspyra, Inc. will demonstrate the workflow efficiencies available within the Company's Laboratory Information System (LIS), Radiology Information System (RIS) and Picture Archive Communication System (PACS) product solutions, with focus on the specific needs and requirements of the rural health environment.
Michelle Del Guercio, Director of Marketing and Product Management states, "Our product solutions are designed to empower rural healthcare providers to experience greater workflow efficiencies with lower costs. Such efficiencies include quicker turnaround of patient results with the use of decision support rules, automatic result verification and report distribution." She continues, "In addition, the Aspyra, Inc. RIS, PACS and LIS solutions enable the facility to adhere to HIPAA and other patient safety requirements with the use of enhanced features and internal audit trails."
Aspyra's AccessRAD RIS/PACS provides a complete imaging department solution that automates all aspects of the patient encounter and image workflow within the radiology environment. CyberLAB LIS is a system used to fully automate and manage complex clinical laboratory processes, meeting the business and operational requirements of today's budget conscious organization.
Safe Harbor Statement
This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for Aspyra's markets and the demand for its products. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of the Company's industry and competition. Factors that could cause Aspyra's actual results to differ materially from these forward-looking statements include among others: whether the combined company will realize the potential benefits of the merger; the competitive environment; unexpected technical and marketing difficulties inherent in major product development efforts; the potential need for changes in our long-term strategy in response to future developments; future advances in clinical information technology and procedures, as well as potential changes in government regulations and healthcare policies; and rapid technological change in the microelectronics and software industries. The Company refers interested persons to its most recent Annual Report on Form 10-KSB and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.
Source: http://www.aspyra.com
Aspyra, Inc. today announced plans to demonstrate the latest release of their AccessRAD RIS/PACS and CyberLAB LIS products at the upcoming NRHA (National Rural Health Association) 2008 Annual Conference held at the Sheraton New Orleans in New Orleans, LA (May 7-10, 2008), Booth 518.
As a clinical and diagnostic solutions provider, Aspyra, Inc. will demonstrate the workflow efficiencies available within the Company's Laboratory Information System (LIS), Radiology Information System (RIS) and Picture Archive Communication System (PACS) product solutions, with focus on the specific needs and requirements of the rural health environment.
Michelle Del Guercio, Director of Marketing and Product Management states, "Our product solutions are designed to empower rural healthcare providers to experience greater workflow efficiencies with lower costs. Such efficiencies include quicker turnaround of patient results with the use of decision support rules, automatic result verification and report distribution." She continues, "In addition, the Aspyra, Inc. RIS, PACS and LIS solutions enable the facility to adhere to HIPAA and other patient safety requirements with the use of enhanced features and internal audit trails."
Aspyra's AccessRAD RIS/PACS provides a complete imaging department solution that automates all aspects of the patient encounter and image workflow within the radiology environment. CyberLAB LIS is a system used to fully automate and manage complex clinical laboratory processes, meeting the business and operational requirements of today's budget conscious organization.
Safe Harbor Statement
This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for Aspyra's markets and the demand for its products. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of the Company's industry and competition. Factors that could cause Aspyra's actual results to differ materially from these forward-looking statements include among others: whether the combined company will realize the potential benefits of the merger; the competitive environment; unexpected technical and marketing difficulties inherent in major product development efforts; the potential need for changes in our long-term strategy in response to future developments; future advances in clinical information technology and procedures, as well as potential changes in government regulations and healthcare policies; and rapid technological change in the microelectronics and software industries. The Company refers interested persons to its most recent Annual Report on Form 10-KSB and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.
Source: http://www.aspyra.com











